Riskpilot← Back to searchSign inGet full accessFysioSpec AB
ABActiveOrg 5592086903Botkyrkavägen 4Rental and operating of own or leased real estate · NACE 6820Est. 20190 employees
Revenue 2024
SEK -12K
-116% vs 2023
EBITDA margin
-1750.0%
+10% vs 2023
Equity ratio
55.3%
Financial strength
Net profit 2024
SEK 147K
+11% vs 2023
| Revenue | SEK -12K | -116% |
| EBITDA | SEK 210K | +10% |
| Net profit | SEK 147K | +11% |
| Total assets | SEK 445K | +4% |
| Equity | SEK 246K | +7% |
| Employees | 0 | — |
Legal name
FysioSpec AB
Org number
5592086903
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
11 juni 2019
Share capital
SEK 51 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall tillhandahålla lokaler för friskvård, konsultverksamhet inom hälso- och sjukvård samt lokaler för sjukvårdande och såsom förenlig verksamhet.
Address
Botkyrkavägen 4
Email
info@fysiospec.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 220 | 187 | 74 | 74 | −12 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 24 | 22 | 307 | 191 | 210 |
| Depreciation & amort. | −0 | −0 | −19 | −19 | −19 |
| EBIT | 24 | 22 | 288 | 172 | 191 |
| Net financials | — | — | −8 | 1 | −1 |
| Profit before tax | 24 | 21 | 280 | 172 | 190 |
| Tax | −2 | −4 | −59 | −39 | −43 |
| Net profit | 22 | 17 | 221 | 133 | 147 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 59 | 78 | 450 | 427 | 445 |
| Equity | 57 | 75 | 296 | 229 | 246 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 | 3 | 155 | 198 | 200 |
| Total debt | 2 | 3 | 155 | 198 | 200 |
EBITDA margin
21000000.0%
This company
15.8%
Market median
+132911292% vs market
20202024
Equity ratio
55.3%
This company
38.2%
Market median
+45% vs market
20202024
Return on equity
59.8%
This company
18.4%
Market median
+225% vs market
20202024
Net profit margin
14700000.0%
This company
8.1%
Market median
+181481381% vs market
20202024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20202024
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FysioSpec AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marcin Lapinski | Board of Directors | 0 companies |
| Ann-Mari Lidström | Deputy Board Member | 0 companies |
| Ewa Repetowicz | Board of Directors | 0 companies |